Short reports and Correspondence| Volume 60, ISSUE 8, P967, August 2007

In response to ‘A late complication following the insertion of hydrogel breast implants’

      The experience of Adams et al.
      • Adams T.S.T.
      • Crook T.
      • Cadier A.A.M.
      A late complication following the insertion of hydrogel breast implants.
      following explantation of a PIP Hydrogel implant is consistent with that of several other UK plastic surgeons who have reported problems to the Medicines and Healthcare products Regulatory Agency (MHRA). The product was recalled from the UK market in December 2000 following an MHRA investigation that revealed inadequate pre-clinical testing. At that time, there was no evidence of toxic effects that would indicate the need for prophylactic explantation and, prior to this, MHRA had received only one report of a problem with this implant. This concerned implant rupture associated with capsular contracture and the presence of approximately 30 ml of straw coloured fluid in the breast pocket. Since the product was withdrawn, around 50 cases have been reported to MHRA, in which breast swelling has typically been associated with the presence of fluid in the pocket surrounding the implant. The manufacturer, PIP, has carried out testing of the periprosthetic fluid, when it has been made available for investigation. However, to date, no new information of clinical significance has come to light either on the nature of the periprosthetic fluid or on any degradation products of the filler material.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Plastic, Reconstructive & Aesthetic Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Adams T.S.T.
        • Crook T.
        • Cadier A.A.M.
        A late complication following the insertion of hydrogel breast implants.
        J Plast Reconstr Aesthet Surg. 2007; 60: 210
      1. The Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment (COT) is an independent scientific committee that provides advice to the Food Standards Agency, the Department of Health and other Government Departments and Agencies on matters concerning the toxicity of chemicals.

      2. COT Statement 2006/03 at


      Linked Article

      • A late complication following the insertion of hydrogel breast implants
        Journal of Plastic, Reconstructive & Aesthetic SurgeryVol. 60Issue 2
        • Preview
          This case report draws attention to an unusual presentation and subsequent complication following the insertion of a PIP Hydrogel® implant for breast augmentation. A cutaneous and capsular foreign body giant cell reaction was identified, and was preceded by the development of a notable increase in breast volume prior to spontaneous discharge. We believe that this was caused by subclinical leakage of the implant contents through a degrading shell. The biodegradability of hydrogel makes it impossible to ascertain the precise nature of the material that leaked out.
        • Full-Text
        • PDF